CHLOMIPHENE CITRATE
Get in touch with us!
An overview
Clomiphene citrate is a drug of the stilbene family designed to induce ovulation in fertility treatments. It is use for:
- Treatment of infertility due to anovulation or dysovulation, normoprolactinemic of functional origin.
- Diagnostic and therapeutic.
- Ovulation induction in assisted reproduction (intrauterine insemination, IVF).
- Product Type: Synthetic ovulation stimulant
- CAS Number: 911-45-5
- Common Indications: Treatment of infertility in women who do not ovulate
- Product Status: Commercial
- Available Grades: Non-Micronized
- Documentation: CEP, US DMF, DMF, CoA, MSDS
Advantages
Efficacy:
Improve chances to patient desiring pregnancy.
No apparent pro-gestational, androgenic, or anti-androgenic effects.
Growing use in male infertility due to proven effectiveness.
Safety:
Administered to patients with ovarian cysts and abnormal vaginal bleeding.
Finished
Dosage Forms
Oral:
Tablets:
50 mg
Global market status
0
M
USD global market sales in 2023
0
MT
consumed globally
0
%
Lorem ipsum solor
Few API manufacturers to cover worldwide demand.
Our API
Clomiphene Citrate
- Clomiphene Citrate is manufactured in accordance with cGMP and stringent international quality standards.
Quality
- The quality control follows every stage from development of analytical methods to the control of manufacturing process.
Samples availables
MINOCYCLINE
PATENT PROTECTION
